UnknownNot Applicable

Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure

France1,000 participantsStarted 2020-09-01

Plain-language summary

Automated quantification of the pulmonary volume impaired during acute respiratory failure could be helpful to assess patient severity during COVID-19 infection or perioperative medicine, for example. This study aim at assessing the correlation between the amount of radiologic pulmonary alteration and the clinical severity in two clinical situation : 1. SARS-CoV-2 infections 2. Postoperative hypoxemic acute respiratory failure

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patient with insurance covering * patient admitted to the participating hospitals for SARS-CoV-2 infection or postoperative acute hypoxemic respiratory failure between 01/01/2019 and 05/11/2020 Exclusion Criteria: \- patient transferred to another hospital than the participating center during the 7 days following the CT scan

What they're measuring

Correlation between altered pulmonary volume and ordinal severity scale

Timeframe: 2 days after CT scan

Trial details

NCT IDNCT04534400

SponsorUniversity Hospital, Strasbourg, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-03-01

Contact for this trial

Eric NOLL, MD

33388127076 eric.noll@chru-strasbourg.fr

View on ClinicalTrials.gov More SARS-CoV-2 Infection trials